Tafasitamab 200mg powder for solution for infusion vials
- SNOMED code
40518411000001100- Active compound
- Tafasitamab
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 vial, vial
- Ingredients
- Tafasitamab
— 200 mg
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Powder for solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Minjuvi 200mg powder for concentrate for solution for infusion vials (Incyte Biosciences UK Ltd)
in short Minjuvi 200mg pdr for concentrate for inf vials
Minjuvi 200mg powder for concentrate for solution for infusion vials
- SNOMED code
40506011000001107- Supplier
- Incyte Biosciences UK Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Minjuvi 200mg powder for concentrate for solution for infusion vials (Incyte Biosciences UK Ltd) 1 vial40506111000001108 ref. pack | 💯 Available Legal category: POM | 9088885500694End: 09088885500694End: 09088885500694 | NHS Indicative Price £705 | • Hospital |
| — |
Reference packs
Tafasitamab 200mg powder for solution for infusion vials 1 vial
- SNOMED code
40505911000001104- Quantity and unit
- 1 vial
- Packs